Skip to main content
. 2015 Nov 9;1:22. doi: 10.1186/s40942-015-0019-2

Fig. 1.

Fig. 1

Baseline lesion size and treatment cycles. Baseline lesion size corresponded significantly to number of treatment cycles required and decreased visual acuity. TTZ triple combination therapy with zeaxanthin, TT triple combination therapy, VA vision. Baseline VA <20/100 = 20/200 or worse vision (p < 0.0001 for baseline VA >20/100 versus baseline VA <20/100, as well as for 2 or less treatment cycles versus 3 or more treatment cycles)